Impact of Cardiac Coherence on Anxiety in Patients Operated on for a Peritoneal Carcinosis

Recruiting now · Not applicable

Conditions studied: Peritoneal Carcinomatosis, Pseudomyxoma Peritonei, Mesothelioma Peritoneum

In brief

The investigator proposes to use the cardiac coherence technique to diminish anxiety before the surgery of a peritoneal carcinosis of colon or stomach or ovary and pseudomyxoma or peritoneal mesothelioma.

Key facts

Study ID

NCT04024917

Run by

Institut du Cancer de Montpellier - Val d'Aurelle

People needed

60

Starts

2021-09-21

Expected to finish

2026-12-01

Last updated by the study team

2026-01-16

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age over 18 years
• Patients with peritoneal carcinosis awaiting cytoreductive surgery
• Patients who scored strictly above 3 on the visual analogue anxiety scale and/or the psychological distress scale
• Patients with sufficient command of the French language
• Patient affiliated to a French social security system
• Patient hospitalized at the Institute of cancer of Montpellier the day before his cytoreductive surgery (at T1 = D-1)
• Signing of informed consent before any specific trial procedure

You may not qualify if…

• Patients who already have daily practice of cardiac coherence
• Presence of proven psychiatric disorders (e.g., mental retardation, psychotic disorders, learning disabilities, attention deficit/hyperactivity, bipolar disorder, etc.) other than mood disorders that are reactive to the disease experience, or receiving psychotic treatment that may impair thinking, judgment or discernment
• Physical or sensory inability to respond to questionnaires
• Patients who have had a heart transplant or bypass surgery in the Year before surgery
• Patient with a history of uncontrolled neurological pathology within the last 6 months before inclusion in the trial
• Patients with a history of psychoactive substance dependence (excluding smoking) in the last 6 months before inclusion in the trial
• Patients with brain metastases
• Known natural bradycardia 50 beats per minute
• Beta-blocker intake in progress
• Ongoing cardiac arrhythmias
• Known severe heart failure with ventricular ejection fraction strictly Below 40 %
• Chronic uncontrolled pain and making it difficult to practice the technique
• Patient with chronic obstructive pulmonary disease
• Legal incapacity (patient under guardianship or curatorship)

Where it is running

• ICM — Montpellier, Hérault, France (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.